CN1319604C - Double layer composite collagen base guide tissue regeneration film and its preparing method - Google Patents
Double layer composite collagen base guide tissue regeneration film and its preparing method Download PDFInfo
- Publication number
- CN1319604C CN1319604C CNB2004100719321A CN200410071932A CN1319604C CN 1319604 C CN1319604 C CN 1319604C CN B2004100719321 A CNB2004100719321 A CN B2004100719321A CN 200410071932 A CN200410071932 A CN 200410071932A CN 1319604 C CN1319604 C CN 1319604C
- Authority
- CN
- China
- Prior art keywords
- collagen
- solution
- sodium salt
- hyaluronic acid
- tissue regeneration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Materials For Medical Uses (AREA)
Abstract
本发明是涉及双层复合胶原基引导组织再生材料及其制备方法,它是以胶原和透明质酸或其钠盐为主要原材料制备成具有致密层和疏松层结构的双层复合材料,质量组成为:所述的致密层是丙二酸胶原溶胀液0.6-0.8%。所述的疏松层是丙二酸胶原溶胀液0.2-0.4%与胶原干重含量5-20%的透明质酸或其钠盐。本发明生物相容性优良,一侧为疏松结构,另一侧为致密结构,使制品具有能阻止成纤维细胞等向缺损处的长入,同时促进缺损处组织的再生修复,具有相应生物学功能,可降解吸收,不必二次手术取出植入材料的显著特点。适用于由于创伤、肿瘤术后等造成的组织缺损,用于缺损组织的引导再生修复,实现缺损组织的再生性愈合。The invention relates to a double-layer composite collagen-based guided tissue regeneration material and a preparation method thereof. It uses collagen and hyaluronic acid or its sodium salt as main raw materials to prepare a double-layer composite material with a dense layer and a loose layer structure. The mass composition For: the dense layer is 0.6-0.8% malonate collagen swelling solution. The loose layer is composed of 0.2-0.4% malonate collagen swelling solution and 5-20% hyaluronic acid or sodium salt of collagen dry weight. The invention has excellent biocompatibility, one side has a loose structure, and the other side has a dense structure, so that the product has the ability to prevent fibroblasts from growing into the defect, and at the same time promote the regeneration and repair of the defect tissue, and has corresponding biological properties. Functional, degradable and absorbable, no need for secondary surgery to take out the remarkable features of implanted materials. It is suitable for tissue defects caused by trauma, tumor surgery, etc., and is used for guided regeneration and repair of defective tissues to achieve regenerative healing of defective tissues.
Description
技术领域technical field
本发明属于生物医用材料领域,特别是涉及一种双层复合胶原基引导组织再生材料及其制备方法。本发明适用于由于创伤、肿瘤术后等造成的组织缺损,用于缺损组织的引导再生修复,实现缺损组织的再生性愈合。作为一种有功能的生物材料,本发明所制备的材料也可以作为组织工程支架用于组织工程化人工器官的研究和开发。The invention belongs to the field of biomedical materials, in particular to a double-layer composite collagen-based guided tissue regeneration material and a preparation method thereof. The invention is applicable to tissue defects caused by trauma, tumor surgery, etc., and is used for guided regeneration and repair of defective tissues, so as to realize regenerative healing of defective tissues. As a functional biomaterial, the material prepared by the invention can also be used as a tissue engineering scaffold for the research and development of tissue engineering artificial organs.
技术背景technical background
医用引导组织再生材料是医用生物材料的重要组成部分,是近几年来发展的一类全新生物材料。引导组织再生(guided tissue regeneration,GTR)的概念80年代首先由N yman等提出,它是指依靠机械屏障等作用,选择性地引导细胞向受损的部位附着、增生,达到组织修复的目的。实现组织病(缺)损的修复和组织引导再生的关键是功能性修复材料的开发和应用。Medical guided tissue regeneration materials are an important part of medical biomaterials and a new type of biomaterials developed in recent years. The concept of guided tissue regeneration (guided tissue regeneration, GTR) was first proposed by Nyman et al. in the 1980s. It refers to relying on mechanical barriers and other functions to selectively guide cells to attach and proliferate to damaged parts to achieve the purpose of tissue repair. The key to realizing tissue disease (defect) repair and tissue-guided regeneration is the development and application of functional repair materials.
作为一种促进组织再生性愈合的全新治疗手段,引导组织再生巧妙的利用膜材料的保护、阻隔作用实现形态和功能上的组织再生或重建,该技术的兴起打破了传统手术疗法的局限性。该技术关键是引导组织再生膜的应用。已有的引导再生材料大多数是由单一材料制备,分为可降解和不可降解两大类。七十年代后期至八十年代初期,Nyman、Gottlow、Becker等人相继对不可降解材料聚缩醛、聚四氟乙烯(PTFE)、硅酮膜等进行了研究,这类材料虽然与组织有较好的生物相容性,但因不能被组织吸收,需要二次手术取出材料,增加了创伤的机会。As a new treatment method to promote tissue regenerative healing, guided tissue regeneration cleverly uses the protection and barrier effect of membrane materials to achieve morphological and functional tissue regeneration or reconstruction. The rise of this technology has broken the limitations of traditional surgical therapy. The key to this technology is the application of guided tissue regeneration membranes. Most of the existing guided recycled materials are prepared from a single material, which can be divided into two categories: degradable and non-degradable. From the late 1970s to the early 1980s, Nyman, Gottlow, Becker and others successively studied non-degradable materials such as polyacetal, polytetrafluoroethylene (PTFE), silicone membrane, etc. Good biocompatibility, but because it cannot be absorbed by the tissue, a second operation is required to remove the material, which increases the chance of trauma.
传统的引导组织再生主要是利用某些生物材料形成的隔膜作用,使得受损组织局部免受周围纤维结缔组织等的影响,从而有利于组织再生修复,但对于需要修复再生的组织并没有很好的促进作用。为更有利于组织修复再生,需要开发新型的材料,所开发的新型GTR材料其应该能阻止成纤维细胞等向缺损处的长入,还应该促进缺损处组织的再生修复,具有生物学功能。通过制备有多层结构的引导组织再生材料可以实现这一目的,已有一些研究工作取得进展。在这些研究工作中,由于主材料的限制(如选用二型胶原制备的材料使其更主要的适用于软骨组织)或者制备工艺的不稳定性(如通过机械压制制备多层膜材料可能出现分层结构的分离)使这些研制成的制品实用性受到影响。选用广泛使用的I型胶原为主材料,同时利用透明质酸或其钠盐具有的促进细胞黏附、增殖和分化的生物学功能,采用更为稳定和简便的制备工艺,可以更好的实现引导组织再生修复的临床需要。The traditional guided tissue regeneration mainly utilizes the membrane effect formed by certain biological materials, so that the damaged tissue is partially protected from the surrounding fibrous connective tissue, etc., which is conducive to tissue regeneration and repair, but it is not very good for the tissue that needs to be repaired and regenerated. promotion. In order to be more conducive to tissue repair and regeneration, it is necessary to develop new materials. The new GTR material developed should be able to prevent fibroblasts from growing into the defect, and should also promote the regeneration and repair of the defect tissue, which has biological functions. This goal can be achieved by preparing guided tissue regeneration materials with a multilayer structure, and some research work has made progress. In these research works, due to the limitation of the main material (such as the selection of type II collagen to make it more suitable for cartilage tissue) or the instability of the preparation process (such as the preparation of multilayer film materials by mechanical pressing, there may be split Separation of the layer structure) affects the practicality of these developed products. The widely used type I collagen is selected as the main material, and at the same time, the biological function of promoting cell adhesion, proliferation and differentiation of hyaluronic acid or its sodium salt is used, and a more stable and simple preparation process can be used to better realize the guidance. Clinical needs for tissue regeneration and repair.
发明内容Contents of the invention
本发明的目的是提供一种双层复合胶原基引导组织再生材料及其制备方法,它是以从牛腱中提取的胶原蛋白为主要原料制备的医用引导组织再生材料。本发明制成的新型医用引导组织再生膜,同时具有胶原材料和透明质酸或其钠盐材料的特点,生物相容性优良,所制备材料为双侧结构不同,一侧为疏松结构,另一侧为致密结构,使制品具有能阻止成纤维细胞等向缺损处的长入,同时促进缺损处组织的再生修复,具有相应生物学功能,可降解吸收,不必二次手术取出植入材料的显著特点。The purpose of the present invention is to provide a double-layer composite collagen matrix guided tissue regeneration material and its preparation method, which is a medical guided tissue regeneration material prepared from collagen extracted from bovine tendon as the main raw material. The novel medical guided tissue regeneration membrane produced by the present invention has the characteristics of collagen material and hyaluronic acid or its sodium salt material, and has excellent biocompatibility. The prepared material has different structures on both sides, one side is a loose structure, and the other One side is a dense structure, so that the product can prevent fibroblasts from growing into the defect, and at the same time promote the regeneration and repair of the defect tissue. It has corresponding biological functions, can be degraded and absorbed, and does not need a second operation to remove the implant material. Notable features.
本发明包括从动物的结缔组织中用蛋白酶消化法提取的胶原蛋白,用0.3%的丙二酸溶液处理使胶原蛋白溶胀,混匀后再用浓度为0.3%的丙二酸溶液调节固体含量,即得到胶原蛋白溶液。分别配制不同含量比例的胶原蛋白溶液,其中低含量比例的胶原蛋白溶液中混合透明质酸或其钠盐,透明质酸或其钠盐的用量为相应低含量比例的胶原蛋白溶液中胶原干重的5-20%,采用通常冷冻干燥和加压成型的方法成型,以常规交联方法使成膜后的胶原蛋白及透明质酸或其钠盐分子间交联,最后再次干燥或冻干已交联的复合胶原蛋白膜材料。The invention comprises the collagen protein extracted from the connective tissue of animals by protease digestion method, treated with 0.3% malonic acid solution to swell the collagen protein, and then adjusting the solid content with 0.3% malonic acid solution after mixing. That is, a collagen solution is obtained. Collagen solutions with different content ratios were prepared respectively, wherein hyaluronic acid or its sodium salt was mixed in the collagen solution with a low content ratio, and the dosage of hyaluronic acid or its sodium salt was the dry weight of collagen in the collagen solution with a corresponding low content ratio The 5-20% of the film is formed by the usual method of freeze-drying and pressure molding, and the collagen and hyaluronic acid or its sodium salt after film formation are cross-linked by conventional cross-linking methods, and finally dried again or freeze-dried. Cross-linked composite collagen membrane material.
为实现本发明的目的,首先应用哺乳动物的结缔组织如牛腱、牛皮、猪腱、猪皮等进行酶处理,制备得到胶原蛋白溶液见中国专利ZL94118836.1。具体内容包括采用酶消化法从牛腱组织中提取I型胶原,并将胶原纤维中具有抗原性的端肽去除,使其具有良好的生物相容性。选用医用级透明质酸或其钠盐并经过氧化等处理,使其具有良好的复合性能。通过共混、多次、多级冻干技术和化学交联,制备双层结构的复合材料,材料中一侧为含有胶原和适度比例的透明质酸或其钠盐的疏松层,另一侧为含有高浓度比例胶原材料的致密层。具体为按比例称取适量的胶原溶胀液适度稀释后预冷冻、合适的条件下冻干处理,冻干材料后处理成为致密结构;按合适的比例分别称取胶原溶胀液和透明质酸或其钠盐分别稀释和溶解,于均匀分散的胶原稀释液中缓慢加入透明质酸或其钠盐溶液,边加边低速搅拌使二者混匀,预冻适当时间形成有一定粘性的冰水结构,后将已制备好的胶原致密层紧密地覆于其上,继续冷冻并进行冻干处理,成为相对疏松/致密的结构;冻干的复合材料经化学交联,清洗冻干处理制备成成品。化学交联所用交联剂可选用醛类、二亚胺类等常用交联剂。得到的产品切割为所需形状,用铝箔或其他软包装材料进行包装,然后用γ-射线照射灭菌。制备过程中可以根据需要,调整致密层和疏松层厚度来调整最终成品的厚度。In order to achieve the purpose of the present invention, firstly, connective tissues of mammals such as bovine tendon, cowhide, pig tendon, pig skin, etc. are used for enzyme treatment to prepare a collagen solution, see Chinese patent ZL94118836.1. The specific content includes extracting type I collagen from bovine tendon tissue by enzymatic digestion, and removing the antigenic telopeptide from the collagen fiber, so that it has good biocompatibility. Medical grade hyaluronic acid or its sodium salt is selected and treated with oxidation to make it have good composite performance. Through blending, multiple times, multi-stage freeze-drying techniques and chemical cross-linking, a composite material with a double-layer structure is prepared. One side of the material is a loose layer containing collagen and a moderate proportion of hyaluronic acid or its sodium salt, and the other side is a loose layer. It is a dense layer containing a high concentration ratio of collagenous material. Specifically, take an appropriate amount of collagen swelling solution in proportion, pre-freeze after appropriate dilution, freeze-dry under suitable conditions, and process the freeze-dried material into a dense structure; weigh collagen swelling solution and hyaluronic acid or its Dilute and dissolve the sodium salt separately, slowly add hyaluronic acid or its sodium salt solution to the evenly dispersed collagen diluent, stir at a low speed while adding to mix the two, and pre-freeze for an appropriate time to form a viscous ice-water structure. Finally, the prepared collagen dense layer is tightly covered on it, and then frozen and freeze-dried to form a relatively loose/dense structure; the freeze-dried composite material is chemically cross-linked, washed and freeze-dried to prepare a finished product. The cross-linking agent used for chemical cross-linking can be selected from commonly used cross-linking agents such as aldehydes and diimines. The obtained products are cut into desired shapes, packed with aluminum foil or other flexible packaging materials, and then sterilized by gamma-ray irradiation. During the preparation process, the thickness of the dense layer and the loose layer can be adjusted to adjust the thickness of the final product as required.
本发明的具体实施方案是:双层复合胶原基引导组织再生材料是以胶原和透明质酸或其钠盐为主要原材料制备成具有致密层和疏松层结构的双层复合材料,质量组成为:The specific embodiment of the present invention is: the double-layer composite collagen-based guided tissue regeneration material is a double-layer composite material with dense layer and loose layer structure prepared from collagen and hyaluronic acid or its sodium salt as the main raw materials, and the mass composition is:
所述的致密层是丙二酸胶原溶胀液 0.6-0.8%。The dense layer is 0.6-0.8% malonate collagen swelling solution.
所述的疏松层是丙二酸胶原溶胀液 0.2-0.4%与胶原干重含量 5-20%的透明质酸或其钠盐。The loose layer is hyaluronic acid or its sodium salt with 0.2-0.4% malonate collagen swelling solution and 5-20% collagen dry weight content.
所述的双层复合胶原基引导组织再生材料的制备方法包括下述步骤:The preparation method of the described double-layer composite collagen-based guided tissue regeneration material comprises the following steps:
(1)按专利94118836.1中所述方法提取制备胶原溶胀液,按计量用0.3%的丙二酸配制成丙二酸胶原溶胀液0.6-0.8%;(1) Extract and prepare collagen swelling liquid according to the method described in patent 94118836.1, and prepare 0.6-0.8% malonate collagen swelling liquid with 0.3% malonic acid according to the metering;
(2)将丙二酸胶原溶胀液倒入合适的容器中置于-35℃的冰箱中2小时,厚度1-3cm,然后在真空冷冻干燥机中,冷冻干燥;(2) Pour the malonic acid collagen swelling solution into a suitable container and place it in a refrigerator at -35°C for 2 hours, with a thickness of 1-3cm, and then freeze-dry it in a vacuum freeze dryer;
(3)将胶原膜置于两个合适大小的平板之间,机械加压使成相对致密层;(3) place the collagen film between two flat plates of appropriate size, and press it mechanically to form a relatively dense layer;
(4)4℃下,将医用级透明质酸或其钠盐用氧化剂高碘酸钠溶液进行氧化处理18小时,然后用亚硫酸氢钠还原未反应残余氧化剂,至无色为止;(4) At 4°C, oxidize the medical grade hyaluronic acid or its sodium salt with an oxidant sodium periodate solution for 18 hours, and then reduce the unreacted residual oxidant with sodium bisulfite until it is colorless;
(5)4℃下,大量对水透析72小时,然后-30℃预东,真空冷冻干燥机中冻干待用。(5) At 4°C, a large amount of water was dialyzed for 72 hours, then pre-heated at -30°C, and freeze-dried in a vacuum freeze dryer for use.
(6)按计量取均匀分散的丙二酸胶原溶胀液0.4-0.8%和经上述处理的透明质酸或其钠盐用0.3%丙二酸或水溶解成溶液,透明质酸或其钠盐用量为胶原干重的5-20%,胶原溶胀液中加入透明质酸或其钠盐溶液,使胶原溶胀液终浓度为0.2-0.4%,搅拌混匀,转移至合适容器中,厚度1-3cm,-30℃预冻30分钟;然后将上述已制备好的胶原致密层紧密地覆于其上,-30℃继续冷冻并进行冻干处理;(6) Take 0.4-0.8% of evenly dispersed malonic acid collagen swelling solution and dissolve the above-mentioned treated hyaluronic acid or its sodium salt with 0.3% malonic acid or water to form a solution, hyaluronic acid or its sodium salt The dosage is 5-20% of the dry weight of collagen. Add hyaluronic acid or its sodium salt solution to the collagen swelling solution to make the final concentration of the collagen swelling solution 0.2-0.4%. Stir and mix well, transfer to a suitable container with a thickness of 1- 3cm, pre-freeze at -30°C for 30 minutes; then cover the dense layer of collagen that has been prepared above tightly, continue to freeze at -30°C and perform lyophilization;
(7)将上述成型的复合材料用常用交联溶液交联,交联后用蒸馏水充分洗涤并浸泡过夜至中性;然后再将其置于合适容器中,并冷冻干燥方法冻干;(7) cross-linking the above-mentioned formed composite material with a common cross-linking solution, after cross-linking, fully wash with distilled water and soak overnight until neutral; then place it in a suitable container, and freeze-dry by freeze-drying method;
(8)从冻干机中取出后,将其置于两个合适大小的平板,压平整,成为最终制品;(8) After taking it out from the lyophilizer, place it on two flat plates of suitable size, press it flat, and become the final product;
(9)切割成不同的规格,包装,然后用γ-射线照灭菌,即得到复合胶原基引导组织再生材料。(9) Cutting into different specifications, packaging, and then sterilizing with gamma-ray irradiation to obtain a composite collagen-based guided tissue regeneration material.
所述的疏松层是0.2-0.4%胶原溶胀液与胶原干重含量5-20%的透明质酸或其钠盐组成。The loose layer is composed of 0.2-0.4% collagen swelling solution and 5-20% hyaluronic acid or sodium salt of collagen dry weight.
所述的疏松层制备步骤中透明质酸或其钠盐溶液加入胶原溶胀液中,还可以用0.1M的Tris碱或0.1M的碳酸氢钠溶液调节pH值至7-9,置20℃恒温空气浴箱内低速搅拌,<60转/每分钟,24小时,使二者发生交联反应,反应结束后,小心弃去过多的液体,余下的固体悬浮液-30℃预冻,至形成疏松层。In the preparation step of the loose layer, hyaluronic acid or its sodium salt solution is added to the collagen swelling solution, the pH value can also be adjusted to 7-9 with 0.1M Tris base or 0.1M sodium bicarbonate solution, and the temperature is kept at 20°C Stir in an air bath at a low speed, <60 rpm, for 24 hours to cause a cross-linking reaction between the two. After the reaction, carefully discard the excess liquid, and pre-freeze the remaining solid suspension at -30°C until it forms Loose layer.
本发明制成的新型医用引导组织再生膜,同时具有胶原材料和透明质酸或其钠盐材料的特点,生物相容性优良,所制备材料为双侧结构不同,一侧为疏松结构,另一侧为致密结构,使制品具有能阻止成纤维细胞等向缺损处的长入,同时促进缺损处组织的再生修复,具有相应生物学功能,可降解吸收,不必二次手术取出植入材料的显著特点。本发明适用于由于创伤、肿瘤术后等造成的组织缺损,用于缺损组织的引导再生修复,实现缺损组织的再生性愈合。作为一种生物材料,本发明所制备的材料也可以作为组织工程支架用于组织工程化人工器官的研究和开发。The novel medical guided tissue regeneration membrane produced by the present invention has the characteristics of collagen material and hyaluronic acid or its sodium salt material, and has excellent biocompatibility. The prepared material has different structures on both sides, one side is a loose structure, and the other One side is a dense structure, so that the product can prevent fibroblasts from growing into the defect, and at the same time promote the regeneration and repair of the defect tissue. It has corresponding biological functions, can be degraded and absorbed, and does not need a second operation to remove the implant material. Notable features. The invention is applicable to tissue defects caused by trauma, tumor surgery, etc., and is used for guided regeneration and repair of defective tissues, so as to realize regenerative healing of defective tissues. As a biological material, the material prepared in the present invention can also be used as a tissue engineering scaffold for the research and development of tissue engineering artificial organs.
附图说明Description of drawings
图1双层膜致密侧表面扫描电镜图像(×50)。Fig. 1 SEM image of the dense side surface of the bilayer film (×50).
图2双层膜致密侧表面扫描电镜图像(×50)。Fig. 2 SEM image of the dense side surface of the bilayer film (×50).
具体实施方式Detailed ways
实施例1Example 1
采用中国专利ZL94118836.1(CN 1086145C)中所述方法提取制备胶原溶胀液,溶胀液用0.3%的丙二酸稀释至0.6%,胶原蛋白稀释的溶胀液100克倒入直径为100mm,高度为2.5cm的玻璃平皿中。将平皿先置于-35℃的冰箱中2小时,取出后迅速将该冻结的平皿置于真空冷冻干燥机的搁板上于真空度为10-100u下冷冻干燥50小时。从冻干机中取出冻干的胶原材料置于两个聚四氟乙烯平板之间,用辊子等平滑物体压平整,使成相对致密层。Adopt the method described in Chinese patent ZL94118836.1 (CN 1086145C) to extract and prepare the collagen swelling solution, the swelling solution is diluted to 0.6% with 0.3% malonic acid, and 100 grams of the swelling solution diluted with collagen protein is poured into a diameter of 100 mm and a height of 100 mm. 2.5cm glass dish. The petri dish was first placed in a refrigerator at -35°C for 2 hours. After taking it out, the frozen petri dish was quickly placed on the shelf of a vacuum freeze dryer and freeze-dried for 50 hours under a vacuum of 10-100u. Take out the lyophilized collagen material from the lyophilizer and place it between two polytetrafluoroethylene plates, and flatten it with a smooth object such as a roller to form a relatively dense layer.
医用级透明质酸钠1克溶解于50ml水中,用20mM高碘酸钠溶液50ml,0.2M高氯酸钠5ml进行氧化处理,4℃18小时,反应结束后缓慢滴加0.04M的亚硫酸氢钠还原未反应残余氧化剂,根据颜色变化确定加入量,至颜色为无色为止,大量对水透析,4℃72小时,每日更换透析用水4次,转移至合适容器中-30℃预冻,真空冷冻干燥机中冻干待用。Dissolve 1 gram of medical-grade sodium hyaluronate in 50ml of water, oxidize with 50ml of 20mM sodium periodate solution, 5ml of 0.2M sodium perchlorate, 18 hours at 4°C, and slowly add 0.04M hydrogen sulfite dropwise after the reaction is completed Sodium reduces the unreacted residual oxidant. Determine the amount to be added according to the color change until the color is colorless. Dialyze a large amount of water at 4°C for 72 hours. Change the dialysis water 4 times a day. Transfer to a suitable container for pre-freezing at -30°C. Freeze-dry in a vacuum freeze dryer for later use.
按合适的比例分别称取胶原溶胀液和经处理的透明质酸钠,分别稀释和溶解,使胶原稀释溶胀液浓度为0.6%50ml,透明质酸钠用量相对胶原干重含量的15%(质量比),用0.3%丙二酸或水溶解于成50ml溶液,均匀分散的胶原稀释液中缓慢加入透明质酸钠溶液,边加边低速搅拌使二者混匀,-30℃预冻适当时间(30分钟左右),形成有一定粘性的冰水结构,将已制备好的胶原致密层紧密地覆于其上,继续冷冻并进行冻干处理,成为双侧致密程度不同的复合材料。Take collagen swelling solution and treated sodium hyaluronate respectively by appropriate ratio, dilute and dissolve respectively, make collagen dilution swelling solution concentration be 0.6% 50ml, sodium hyaluronate consumption is 15% (mass) relative to collagen dry weight content ratio), use 0.3% malonic acid or water to dissolve in 50ml solution, slowly add sodium hyaluronate solution to the uniformly dispersed collagen diluent, stir at low speed while adding to mix the two, and pre-freeze at -30°C for an appropriate time (about 30 minutes), a viscous ice-water structure is formed, and the prepared collagen dense layer is tightly covered on it, and then frozen and freeze-dried to become a composite material with different densities on both sides.
将按上述方法制得的成型的复合材料用浓度为pH为8.4的甲醛溶液交联120分钟,交联后用蒸馏水充分洗涤10-15次并浸泡过夜至中性。然后再将其置于玻璃平皿中,预冻后冷冻干燥方法冻干。从冻干机中取出后,再次将膜置于两个聚四氟乙烯板中压平整,成为最终制品。The molded composite material prepared by the above method is crosslinked for 120 minutes with a formaldehyde solution with a pH of 8.4, and after crosslinking, it is fully washed with distilled water for 10-15 times and soaked overnight until neutral. Then it is placed in a glass plate, pre-frozen and then freeze-dried. After removal from the lyophilizer, the membrane was again placed between two Teflon plates and flattened to become the final product.
切割成不同的规格,用铝箔或其他软包装材料进行包装,然后用剂量为25kGy的γ-射线照灭菌,即得到复合胶原基引导组织再生材料。图1双层膜致密侧表面扫描电镜图像(×50)。图2双层膜致密侧表面扫描电镜图像(×50)。Cut into different specifications, pack with aluminum foil or other soft packaging materials, and then sterilize with gamma-ray irradiation at a dose of 25kGy to obtain a composite collagen matrix-guided tissue regeneration material. Fig. 1 SEM image of the dense side surface of the bilayer film (×50). Fig. 2 SEM image of the dense side surface of the bilayer film (×50).
实施例2Example 2
致密胶原层和透明质酸钠处理同实施例1。The dense collagen layer and the treatment with sodium hyaluronate are the same as in Example 1.
疏松层制备过程为:称取适量胶原溶胀液和经处理的透明质酸钠,分别稀释和溶解,浓度和比例同实施例1,将透明质酸钠溶液加入胶原溶胀液中,用0.1M的Tris碱或0.1M的碳酸氢钠溶液调节pH值至7-9,置20℃恒温空气浴箱内低速(<60转每分钟)摇动24小时,使经氧化处理的透明质酸钠分子与胶原发生交联反应。反应结束后,小心弃去过多的液体,余下的固体悬浮液按实施例1中条件预冻,至形成一定粘性的冰水结构时紧密覆盖已制备好的致密层,继续预冻至完全成冰样结构,冻干处理。冻干样品于机械装置中压制成形,切片,包装,用剂量为25kGy的γ-射线照灭菌,即得到复合胶原基引导组织再生材料。The preparation process of the loose layer is as follows: Weigh an appropriate amount of collagen swelling solution and treated sodium hyaluronate, dilute and dissolve respectively, the concentration and ratio are the same as in Example 1, add the sodium hyaluronate solution into the collagen swelling solution, and use 0.1M Adjust the pH value to 7-9 with Tris base or 0.1M sodium bicarbonate solution, and shake it in a constant temperature air bath at 20°C for 24 hours at a low speed (<60 rpm) to make the oxidized sodium hyaluronate molecules and collagen A crosslinking reaction occurs. After the reaction, carefully discard the excess liquid, and prefreeze the remaining solid suspension according to the conditions in Example 1 until a certain viscous ice-water structure is formed to tightly cover the prepared dense layer, and continue to prefreeze until it is completely formed. Ice-like structure, freeze-dried. The freeze-dried sample was pressed into a mechanical device, sliced, packaged, and sterilized by gamma-ray irradiation at a dose of 25 kGy to obtain a composite collagen-based guided tissue regeneration material.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100719321A CN1319604C (en) | 2004-09-13 | 2004-09-13 | Double layer composite collagen base guide tissue regeneration film and its preparing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100719321A CN1319604C (en) | 2004-09-13 | 2004-09-13 | Double layer composite collagen base guide tissue regeneration film and its preparing method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1586637A CN1586637A (en) | 2005-03-02 |
| CN1319604C true CN1319604C (en) | 2007-06-06 |
Family
ID=34604651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100719321A Expired - Fee Related CN1319604C (en) | 2004-09-13 | 2004-09-13 | Double layer composite collagen base guide tissue regeneration film and its preparing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1319604C (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101954126A (en) * | 2010-09-26 | 2011-01-26 | 华南理工大学 | Method for preparing bionic modified collagen tissue repair material |
| CN102716517B (en) * | 2011-03-30 | 2015-01-14 | 深圳兰度生物材料有限公司 | Guided tissue regeneration membrane and its preparation method |
| CN103191085B (en) * | 2012-01-09 | 2016-08-03 | 深圳兰度生物材料有限公司 | A kind of two-layer compound regeneration membrane and preparation method thereof |
| CN104225689A (en) * | 2013-06-08 | 2014-12-24 | 北京航空航天大学 | Preparation method of fish collagen bone-induced regeneration membrane |
| CN105457107B (en) * | 2016-01-12 | 2018-07-31 | 四川大学 | A kind of bifunctional layer oral restoration film and preparation method thereof |
| CN106730037B (en) * | 2016-11-17 | 2019-12-13 | 北京华信佳音医疗科技发展有限责任公司 | A kind of composite collagen biofilm and preparation method thereof |
| CN107050519B (en) * | 2016-12-22 | 2021-04-13 | 天新福(北京)医疗器材股份有限公司 | Preparation method of multilayer absorbable biological membrane |
| CN107412869B (en) * | 2017-04-10 | 2020-06-09 | 中国医学科学院生物医学工程研究所 | Collagen-based double-layer membrane material for directionally releasing load growth factors and manufacturing method thereof |
| CN107551324B (en) * | 2017-10-27 | 2020-02-18 | 北京华信佳音医疗科技发展有限责任公司 | Preparation and application of suturable hard membrane repairing material |
| CN108744064B (en) * | 2018-06-27 | 2021-04-20 | 山东大学齐鲁医院 | A kind of three-dimensional biological scaffold material and preparation method |
| CN111035812A (en) * | 2019-12-20 | 2020-04-21 | 厦门大学附属中山医院 | Human-derived cell biological composite patch |
| CN113372436A (en) * | 2021-07-08 | 2021-09-10 | 中国海洋大学 | Medical collagen membrane with compact fish skin outer layer and loose inner layer and preparation method thereof |
| CN116570770B (en) * | 2023-07-12 | 2023-11-07 | 天新福(北京)医疗器材股份有限公司 | Double-layer freeze-drying tube and preparation method and application thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6141452A (en) * | 1984-08-02 | 1986-02-27 | 株式会社 高研 | Artificial skin |
| FR2657352A1 (en) * | 1990-01-25 | 1991-07-26 | France Etat Armement | New biological product for replacement of connective tissue, with a composite structure based on collagen, and process for its preparation |
| CN1158573A (en) * | 1994-09-30 | 1997-09-03 | 山之内制药株式会社 | Osteoplastic graft |
| CN1337270A (en) * | 2000-08-07 | 2002-02-27 | 黄玲惠 | Wound dressing and method for its preparation |
| EP1262200A2 (en) * | 1994-06-07 | 2002-12-04 | Genzyme Corporation | Inhibition of platelet adherence and aggregation |
-
2004
- 2004-09-13 CN CNB2004100719321A patent/CN1319604C/en not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6141452A (en) * | 1984-08-02 | 1986-02-27 | 株式会社 高研 | Artificial skin |
| FR2657352A1 (en) * | 1990-01-25 | 1991-07-26 | France Etat Armement | New biological product for replacement of connective tissue, with a composite structure based on collagen, and process for its preparation |
| EP1262200A2 (en) * | 1994-06-07 | 2002-12-04 | Genzyme Corporation | Inhibition of platelet adherence and aggregation |
| CN1158573A (en) * | 1994-09-30 | 1997-09-03 | 山之内制药株式会社 | Osteoplastic graft |
| CN1337270A (en) * | 2000-08-07 | 2002-02-27 | 黄玲惠 | Wound dressing and method for its preparation |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1586637A (en) | 2005-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Alizadeh et al. | Microstructure and characteristic properties of gelatin/chitosan scaffold prepared by a combined freeze-drying/leaching method | |
| Zhu et al. | Recent progress of polysaccharide‐based hydrogel interfaces for wound healing and tissue engineering | |
| CN1319604C (en) | Double layer composite collagen base guide tissue regeneration film and its preparing method | |
| CN102886063B (en) | Preparation and application of cellulose nanocrystals (CNCs)-reinforced collagen compound substrate | |
| CN101954126A (en) | Method for preparing bionic modified collagen tissue repair material | |
| JP6720279B2 (en) | Denatured collagen | |
| CN103710409B (en) | Microporous starch with controllable degradation rate and preparation method thereof | |
| SK10362003A3 (en) | A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and en elongated collagen sponge | |
| Lin et al. | 3D printed alginate/gelatin-based porous hydrogel scaffolds to improve diabetic wound healing | |
| CN110812529B (en) | Injectable hydrogel and preparation method thereof | |
| CN106039416A (en) | Chitosan-sericin composite biological scaffold as well as preparation method and application thereof | |
| CN1259980C (en) | Biologic material for medical use and its preparing process and usage | |
| CN1674946A (en) | Orthopaedic materials derived from keratin | |
| Yang et al. | Transforming natural silk nonwovens into robust bioadhesives for in vivo tissue amendment | |
| CN101264337B (en) | Preparation of collagen base biological medical material | |
| CN103961752B (en) | Tissue regeneration guiding film and preparation method thereof | |
| CN117482036A (en) | Methacrylic acylated sericin microneedle and preparation method and application thereof | |
| CN109985271B (en) | Composite collagen dressing for healing-difficult wound repair and preparation method thereof | |
| CN107715181B (en) | A kind of preparation method of biodegradable tissue engineering skin scaffold | |
| CN102757625B (en) | A kind of chitosan-polylactic acid is composite porous and preparation method thereof | |
| WO2025129961A1 (en) | Method for preparing composite bioactive inorganic silicate hydrogel-based wound dressing | |
| CN105879101A (en) | Feather keratin-based biopolymer external application material and preparation method thereof | |
| CN113398317B (en) | Hemostatic material and preparation method thereof | |
| CN117298332A (en) | Injectable double-network hydrogel with immune regulation function and preparation method and application thereof | |
| CN100402097C (en) | Agar/collagen skin wound repair dressing and its preparation method and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070606 Termination date: 20200913 |